BROWN-SEQUARD SYNDROME

BROWN-SEQUARD SYNDROME was reported 68 times

These drug classes are most commonly taken by patients reporting BROWN-SEQUARD SYNDROME:

# Drug Count
0 Corticosteroid [EPC] 13
1 Benzodiazepine [EPC] 7
2 5-alpha Reductase Inhibitor [EPC] 5
3 Factor Xa Inhibitor [EPC] 5
4 Proton Pump Inhibitor [EPC] 5
5 Tumor Necrosis Factor Blocker [EPC] 5
6 Nonsteroidal Anti-inflammatory Drug [EPC] 4
7 Platelet Aggregation Inhibitor [EPC] 4
8 Amide Local Anesthetic [EPC] 3
9 Angiotensin 2 Receptor Blocker [EPC] 3
10 Catecholamine [EPC] 3
11 Nucleoside Metabolic Inhibitor [EPC] 3
12 Opioid Agonist [EPC] 3
13 P2Y12 Platelet Inhibitor [EPC] 3
14 alpha-Adrenergic Agonist [EPC] 3
15 beta-Adrenergic Agonist [EPC] 3
16 Azole Antifungal [EPC] 2
17 CD20-directed Cytolytic Antibody [EPC] 2
18 CD38-directed Cytolytic Antibody [EPC] 2
19 Dietary Cholesterol Absorption Inhibitor [EPC] 2
20 Folate Analog Metabolic Inhibitor [EPC] 2
21 Glinide [EPC] 2
22 Integrin Receptor Antagonist [EPC] 2
23 Platinum-based Drug [EPC] 2
24 Proteasome Inhibitor [EPC] 2
25 Provitamin D2 Compound [EPC] 2
26 Xanthine Oxidase Inhibitor [EPC] 2
27 Alkylating Drug [EPC] 1
28 Antimetabolite Immunosuppressant [EPC] 1
29 Calcium Channel Blocker [EPC] 1
30 Cholinergic Nicotinic Agonist [EPC] 1
31 Dihydropyridine Calcium Channel Blocker [EPC] 1
32 Fluoroquinolone Antibacterial [EPC] 1
33 Glycopeptide Antibacterial [EPC] 1
34 HER2/neu Receptor Antagonist [EPC] 1
35 HMG-CoA Reductase Inhibitor [EPC] 1
36 Humanized Monoclonal Antibody Fragment [EPC] 1
37 Insulin [EPC] 1
38 Interferon beta [EPC] 1
39 Interleukin-6 Receptor Antagonist [EPC] 1
40 Leukocyte Growth Factor [EPC] 1
41 Lipid-based Polyene Antifungal [EPC] 1
42 Microtubule Inhibitor [EPC] 1
43 Penem Antibacterial [EPC] 1
44 Polyene Antifungal [EPC] 1
45 Purine Antimetabolite [EPC] 1
46 Serotonin Reuptake Inhibitor [EPC] 1
47 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
48 Vitamin C [EPC] 1
49 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1